Skip to content

Clinical trials

Completed Multiple Myeloma trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Completed Country / region: Norway Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20052
20061
20071
20092
20111
20122
20132
20143
20151
20163
20173
20191
20202
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene5
Nordic Myeloma Study Group3
AbbVie2
Amgen2
Genentech, Inc.2
Norwegian University of Science and Technology2
Novartis Pharmaceuticals2
Ullevaal University Hospital2
Bristol-Myers Squibb1
European Society for Blood and Marrow Transplantation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma30
Recurrence7
Neoplasms, Plasma Cell3
Neoplasms2
Biliary Tract Neoplasms1
Gastrointestinal Stromal Tumors1
Glioma1
Leukemia, Hairy Cell1
Thyroid Carcinoma, Anaplastic1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.